L-dopa decarboxylase in CSF

From Aaushi

Jump to navigation Jump to search

^[1]

Indications

evaluation of Parkinson's disease, Lewy body dementia & Parkinson-plus syndromes

* L-dopa decarboxylase = aromatic L-amino acid decarboxylase

More general terms

special chemistry test

References

↑ Pereira JB, Kumar A, Hall S et al DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body disease. Nat Aging 2023. Sept 18 PMID: https://www.ncbi.nlm.nih.gov/pubmed/37723208 https://www.nature.com/articles/s43587-023-00478-y

Retrieved from "https://aaushi.info/w/index.php?title=A58357&oldid=1171236"

↑ Back to top